A target trial emulation study found no increased risk for suicidal thoughts or behaviors associated with the use of GLP-1RAs (glucagon-like peptide-1 receptor agonists) to treat type 2 diabetes (T2D).
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
